ARS Pharmaceuticals Inc

NASDAQ:SPRY

16.52

-0.23 (-1.37%)

4:43:41 PM EDT: $16.85 +0.33 (+2.00%)

Market Cap (Intraday)	1.60B
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$13.77 Million
Adjusted EPS	-$0.46

See more estimates

10-Day MA	N/A
50-Day MA	N/A
200-Day MA	N/A

See more pivots

ARS Pharmaceuticals Inc Stock, NASDAQ:SPRY

11682 El Camino Real, Suite 120, San Diego, California 92130

United States of America

Phone: +1.206.456.2900

Number of Employees: 26

http://www.ars-pharma.com

Description

ARS Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on the development of a novel, potentially first-in-class product candidate, neffy, for the emergency treatment of Type I allergic reactions including anaphylaxis. Its product includes Epinephrine Nasal Spray. The company was founded by Richard Lowenthal, Robert Bell, and Sarina Tanimoto on August 5, 2015 and is headquartered in San Diego, CA.